CFO to CFO

“In MedTech, growth isn’t enough — enterprise value is everything. With capital tight and execution under a microscope, every misstep costs us. Most transformations fail because strategy never meets operations.”
— MedTech CEO
In today’s environment, CFOs are navigating pressures that
go far beyond finance:
  • Capital efficiency — Rising interest rates and tighter credit mean every investment must prove near-term ROI.
  • Margin protection — McKinsey reports median EBITDA margins in MedTech have compressed by 200–300 bps over the last two years due to inflation, labor shortages, and cost-to-serve increases.
  • Revenue predictability — Longer sales cycles and uncertain reimbursement timelines challenge forecasting accuracy.
  • Investor scrutiny — JP Morgan notes that healthcare investors now prioritize cash flow resilience and disciplined capital allocation over aggressive growth plays.
  • Transformation fatigue — 70% of large-scale change programs fail to deliver promised financial outcomes, eroding credibility with boards.
At NextAccel, we work alongside CFOs to turn these headwinds into levers — aligning capital, operations, and go-to-market for measurable valuation impact.
Because in this market, the question isn’t just “Are we growing?” — it’s “Are we growing in ways the market rewards?”
Identify and activate the hidden levers that move your valuation.

DATA VISUALIZATION SERIES

CFO Data Point

McKinsey finds that CFOs who rigorously link capital allocation to enterprise value drivers deliver 2.6x higher TSR than peers. Bain reports that disciplined reallocators shift at least 60% of capital over a decade, yet most companies move less than 10% — leaving value on the table.
Our CFO Data Point distills market intelligence to show where financial leaders are deploying capital, the ROI signals investors reward, and the trade-offs shaping valuation trajectories.
In today’s market, every allocation is more than spend — it’s a statement of strategic intent.

Trending with CFOs

From volatile capital markets to margin-squeezing inflation, CFOs today are making faster, higher-stakes decisions than ever before. Based on our work with finance leaders across industries, we’ve distilled the insights shaping valuation in 2025 — the moves your peers are making to safeguard and grow enterprise value.

The CFO
Playbook
for Enterprise
Value
Today’s CFOs are navigating a market where every decision — from capital allocation to tech adoption — is a valuation lever. The CFO Playbook distills proven strategies from high-performing finance leaders on sustaining profitability, boosting investor confidence, and positioning for a stronger exit.
These capabilities help you balance growth with resilience, turning market headwinds into enterprise value gains.
Your roadmap to measurable enterprise growth.

CAPABILITY

Capital Allocation Excellence
Ensure every dollar deployed drives measurable value, with frameworks to balance near-term ROI and long-term strategic advantage.
CAPABILITY
Margin Optimization
Combat cost pressures through smarter pricing, leaner operations, and data-driven efficiency gains.

CAPABILITY

Forecasting Precision
Leverage advanced analytics to improve predictability, reduce surprises, and build investor trust.
Ready to unlock valuation gains?
Schedule a Value Growth Call to identify the financial, operational,
and GTM levers that will strengthen your enterprise value — and your exit position.
Map the fastest path from today’s balance sheet to tomorrow’s market premium.